Quick Takeaways
- Terry-Ann Burrell has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $3,647,956.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Terry-Ann Burrell and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| BEAM | Beam Therapeutics Inc. | Chief Financial Officer | $3,133,858 | 26 Apr 2024 | ||
| RXRX | RECURSION PHARMACEUTICALS, INC. | Director | $514,098 | 01 Jul 2024 | ||
| RAPP | Rapport Therapeutics, Inc. | Director | 06 Jun 2024 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|